Adial Pharmaceuticals, Inc. (AZR) stock

AZRNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ADIL

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Oct 21, 2026Score 5/30

Share price

Not available yet

Price, market cap and P/E appear here once daily prices are connected.

Adial Pharmaceuticals statistics

57 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Nov 13, 2026 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Oct 27, 2026

Valuation ratiosIndustry

Market Cap: $9.74M; $265.71M
Enterprise Value: -$18.97M; $146.54M

Share statisticsIndustry

Shares Outstanding: 3M; 58M
Shares Change (YoY): 577.6%; 10.8%
Shares Change (QoQ): 74.0%; 0.54%
Float: 2M; 49M
Shares Held by Insiders: 32.0%; 11.4%
Shares Held by Institutions: 5.20%; 56.1%

Short sellingIndustry

Short Interest: 183,323; –
Short Interest Change: -12.7%; 0.60%
Short % of Float: 10.3%; 9.30%
Short % of Shares Outstanding: 6.98%; 6.60%
Days to Cover: 4.28; 4.58

Stock price statisticsIndustry

52-Week High: $9.50; –
52-Week Low: $1.31; –
20-Day Moving Average: $3.80; –
50-Day Moving Average: $4.76; –
200-Day Moving Average: $3.24; –
Average True Range (14): $0.42; –
Price Change (1 Week): -2.88%; 1.30%
Price Change (1 Month): -8.17%; -7.60%
Price Change (3 Months): 17.8%; -14.4%
Price Change (6 Months): 137.8%; -19.7%
Price Change (YTD): -32.5%; -19.6%
Price Change (1 Year): -58.8%; -21.9%
Price Change (3 Years): -92.3%; -22.6%
Price Change (5 Years): -99.8%; -75.5%
Average Volume (10 Days): 20,838; –
Average Volume (20 Days): 32,409; –
Average Volume (90 Days): 54,375; –
Relative Volume: 0.13; 0.73
Relative Strength Index (14): 44.5; 44.2
Volatility (1 Year): 102.9%; 79.5%
Beta (5 Years): 0.81; 1.07

Returns on capitalIndustry

Return on Assets (ROA): -322.1%; -40.9%
Return on Capital Employed (ROCE): -240.6%; -38.6%

Financial positionIndustry

Current Ratio: 5.63; 3.30
Quick Ratio: 5.61; 2.39

EfficiencyIndustry

Profits Per Employee: -$9.63M; -$705.27K
Employee Count: 6; 75
WACC: 9.03%; 10.1%

Income statement (TTM)Industry

Operating Income: -$57.68M; -$21.42M
Net Income: -$57.80M; -$22.46M
EBITDA: -$57.68M; -$16.82M

Balance sheetIndustry

Cash & Short-Term Investments: $28.71M; $61.68M
Net Cash (Debt): $28.71M; $15.31M
Net Cash Per Share: $10.93; $0.66
Equity (Book Value): -$38.38M; $48.79M
Book Value Per Share: -$14.61; $1.36
Tangible Book Value: -$38.38M; $23.91M
Working Capital: $23.72M; $74.41M

Cash flow (TTM)Industry

Operating Cash Flow: -$11.13M; -$12.24M

Dividends and yieldsIndustry

Earnings Yield: -593.3%; -20.7%
Buyback Yield: -17.4%; -0.51%
Shareholder Yield: -17.4%; 0.00%

Scores and fair valueIndustry

Altman Z-Score: -12.29; 0.25
Piotroski F-Score: 4; 4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.